E-therapeutics Plc
ETXPF · OTC
1/31/2025 | 7/31/2024 | 1/31/2024 | 7/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,607 | -$6,286 | -$5,577 | -$5,587 |
| Dep. & Amort. | $312 | $267 | $264 | $271 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $0 | $0 | $0 |
| Change in WC | -$148 | -$731 | $1,051 | -$247 |
| Other Non-Cash | -$170 | -$988 | $623 | -$189 |
| Operating Cash Flow | -$8,602 | -$7,738 | -$3,639 | -$6,539 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36 | -$635 | -$373 | -$108 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$11,687 | $0 | $0 | $0 |
| Investing Cash Flow | -$11,723 | -$635 | -$373 | -$108 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $29,018 | $15 | $22 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$199 | -$8,334 | -$186 | -$210 |
| Financing Cash Flow | -$199 | $28,829 | -$171 | -$188 |
| Forex Effect | $0 | $0 | $0 | $1,275 |
| Net Chg. in Cash | -$41,043 | $41,043 | -$4,480 | -$5,560 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,043 | $0 | $25,165 | $30,373 |
| End Cash | $0 | $41,200 | $20,685 | $24,812 |
| Free Cash Flow | -$8,638 | -$8,113 | -$4,013 | -$6,647 |